Merck KGaA goes hostile in $5.9 billion Versum takeover battle
FRANKFURT (Reuters) – German pharma group Merck KGaA launched a hostile $5.9 billion all-cash takeover offer for Versum Materials on…
Merck KGaA’s lung cancer drugs show promise in early-stage trials
FRANKFURT (Reuters) – Germany’s Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain…